Inhalation Injuries

1990 ◽  
Vol 1 (3) ◽  
pp. 535-542 ◽  
Author(s):  
Karen A. Fitzgerald ◽  
Evelyn Gonzales McLaughlin

Inhalation injuries comprise three distinct clinical entities that may be classified according to the time of onset of symptoms, etiologic agents, and the anatomic location of injury. These entities are carbon monoxide toxicity, upper airway obstruction, and smoke inhalation or chemical injury. Each has a distinct pathophysiology, clinical manifestations, treatment, and prognosis. The emergency management of inhalation injury is frequently based on the health professional’s degree of suspicion despite the availability of sophisticated diagnostic tests. Early aggressive treatment, including maintaining a patent airway, administering humidified oxygen and bronchodilators, and providing pulmonary toilet, is necessary to ensure the best possible outcome. Understanding the pathophysiology, clinical manifestations, diagnosis, medical management, and nursing implications of inhalation injuries can improve patient survival

Author(s):  
Wilson Bizimana ◽  
Gloria Akimana ◽  
Arthur Semedo Insumbo ◽  
Hounayda Jerguigue ◽  
Rachida Latib ◽  
...  

AbstractMalignant melanoma of vagina is a rare condition. Its histogenesis has been debated and the positive diagnosis is based on immunohistochemistry. Pelvic magnetic resonance imaging remains the gold standard for assessing locoregional extension status and post-treatment surveillance of melanoma of vagina. The observation concerned a 53-year-old woman with no specific history who presented a primary malignant melanoma of vagina without secondary locations. To date, the case is the second one reported in the literature. Early diagnosis of the malignant melanoma of vagina may improve patient survival because late diagnoses are punctuated by poor prognosis. We have presented epidemiological with etiopathogenic characteristics and described all imaging features to stage the tumor and to conduct the appropriate treatment.


2013 ◽  
Author(s):  
Marina Rigau ◽  
Blanca Majem ◽  
Tatiana Altadill ◽  
Lucia Lanau ◽  
José-Luis Sánchez-Iglesias ◽  
...  

Author(s):  
Scott C. Corbett ◽  
Hamid N.-Hashemi ◽  
Ahmet U. Coskun

While heart valve prostheses have been used successfully since 1960, outcomes are far from ideal. The underlying problem with bioprostheses is a limited life from structural changes such as calcification and leaflet wear, leading to valve failure. The underlying problem with mechanical heart valves is the presence of flow disturbances which necessitate anticoagulation. A polyurethane valve has the potential to improve upon the shortcomings of existing valves and ultimately improve patient survival.


2019 ◽  
Vol 12 ◽  
pp. 2632010X1983126
Author(s):  
Yuki Nakamura ◽  
Koichi Toda ◽  
Shigeru Miyagawa ◽  
Yasushi Yoshikawa ◽  
Hiroki Hata ◽  
...  

Cardiac sarcoma treatment is challenging for surgeons because of frequent tumor recurrence and poor prognosis. In addition, optimal management of recurrences is not well established. The multi-targeted tyrosine kinase inhibitor, pazopanib, was recently approved for soft-tissue sarcoma. Herein, we present a case involving recurrent cardiac angiosarcoma where the patient survived for 2 years with complete remission of disease after repeated surgical resection and treatment with oral pazopanib. Based on our experience, aggressive surgical resection combined with pazopanib may be a valid treatment for recurrent cardiac angiosarcoma to improve patient survival.


2006 ◽  
Vol 26 (5) ◽  
pp. 543-551 ◽  
Author(s):  
Hironori Tanaka ◽  
Kazuhiro Nouso ◽  
Haruhiko Kobashi ◽  
Yoshiyuki Kobayashi ◽  
Shin-ichiro Nakamura ◽  
...  

2017 ◽  
Vol 14 (3) ◽  
pp. 3035-3038 ◽  
Author(s):  
Aldo Pezzuto ◽  
Fabrizio Terzo ◽  
Maria Laura Graziani ◽  
Alberto Ricci ◽  
Pierdonato Bruno ◽  
...  

2019 ◽  
Vol 25 (19) ◽  
pp. 5972-5983 ◽  
Author(s):  
Wei Tang ◽  
Vasanta Putluri ◽  
Chandrashekar R. Ambati ◽  
Tiffany H. Dorsey ◽  
Nagireddy Putluri ◽  
...  

2016 ◽  
Vol 16 (5) ◽  
pp. 447-464 ◽  
Author(s):  
R. Alcedo-Guardia ◽  
E. Labat ◽  
D. Blas-Boria ◽  
P.E. Vivas-Mejia

1994 ◽  
Vol 19 (4) ◽  
pp. 317-319 ◽  
Author(s):  
L. S. Langmo ◽  
A. P. Dagher ◽  
W. B. Mehard ◽  
W. C. Small ◽  
J. P. Heiken ◽  
...  

2018 ◽  
Vol 46 (12) ◽  
pp. 5228-5236 ◽  
Author(s):  
Lanyun Feng ◽  
Qi Qi ◽  
Peng Wang ◽  
Hao Chen ◽  
Zhen Chen ◽  
...  

Objective Early detection and prognosis prediction are critical to improve patient survival in pancreatic cancer. This study aimed to investigate whether interleukins could serve as indicators of prognosis in pancreatic cancer. Methods Sixty-eight patients with pancreatic cancer were enrolled in the study during the period between 2012 and 2014. The serum levels of a broad spectrum of interleukins in these patients were determined, including IL-1β, IL-2, IL-6, IL-8, IL-10, IL-13, IL-15, and IL-23. Results IL-6, IL-8, and IL-10 showed significant positive correlations with each other. Moreover, high levels of serum IL-6, IL-8, and IL-10 were independently strongly associated with poor survival of patients with pancreatic cancer. Conclusions Our results suggest that serum levels of IL-6, IL-8, and IL-10 could be useful markers for prediction of prognosis in patients with pancreatic cancer.


Sign in / Sign up

Export Citation Format

Share Document